- Home
- PYPD vs GLXG Comparison
PYPD vs GLXG Comparison
Compare PYPD & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- GLXG
- Stock Information
- Founded
- PYPD 2008
- GLXG 2013
- Country
- PYPD Israel
- GLXG Hong Kong
- Employees
- PYPD N/A
- GLXG N/A
- Industry
- PYPD Medical/Dental Instruments
- GLXG
- Sector
- PYPD Health Care
- GLXG
- Exchange
- PYPD Nasdaq
- GLXG NYSE
- Market Cap
- PYPD 19.4M
- GLXG 15.8M
- IPO Year
- PYPD 2020
- GLXG 2024
- Fundamental
- Price
- PYPD $3.30
- GLXG $1.22
- Analyst Decision
- PYPD Strong Buy
- GLXG
- Analyst Count
- PYPD 2
- GLXG 0
- Target Price
- PYPD $10.50
- GLXG N/A
- AVG Volume (30 Days)
- PYPD 49.0K
- GLXG 3.2M
- Earning Date
- PYPD 02-12-2025
- GLXG 02-16-2025
- Dividend Yield
- PYPD N/A
- GLXG N/A
- EPS Growth
- PYPD N/A
- GLXG N/A
- EPS
- PYPD N/A
- GLXG 0.04
- Revenue
- PYPD N/A
- GLXG $3,858,088.00
- Revenue This Year
- PYPD N/A
- GLXG N/A
- Revenue Next Year
- PYPD N/A
- GLXG N/A
- P/E Ratio
- PYPD N/A
- GLXG $27.68
- Revenue Growth
- PYPD N/A
- GLXG N/A
- 52 Week Low
- PYPD $2.37
- GLXG $0.70
- 52 Week High
- PYPD $7.00
- GLXG $16.93
- Technical
- Relative Strength Index (RSI)
- PYPD 55.20
- GLXG N/A
- Support Level
- PYPD $2.93
- GLXG N/A
- Resistance Level
- PYPD $3.35
- GLXG N/A
- Average True Range (ATR)
- PYPD 0.24
- GLXG 0.00
- MACD
- PYPD 0.04
- GLXG 0.00
- Stochastic Oscillator
- PYPD 93.15
- GLXG 0.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About GLXG GALAXY PAYROLL GROUP LTD
Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.